Company: AEMD
Filing Date: 2025-06-05
Form Type: 8-K
Source: 0001683168-25-004248
Chunk: 0

Company: AETHLON MEDICAL INC
Filing Date: 2025-06-05
Form: 8-K
Item: Item 8.01
Chunk 0
---
Item 8.01 Other Events.

As previously reported
on the Current Report on Form 8-K of Aethlon Medical, Inc. (the “ Company”), as filed with the Securities and Exchange Commission
on May 13, 2025, at the Company’s Special Meeting of Stockholders held on May 13, 2025 (the “ Special Meeting”), the
Company’s stockholders approved, pursuant to Nevada Revised Statutes (“ NRS”) 78.2055, a reverse stock split of the Company’s
common stock at a ratio in the range of 1-for-5 to 1-for-12, with such ratio to be determined in the discretion of the Company’s
Board of Directors (the “ Board”) and with such reverse stock split to be effected at such time and date as determined by the
Board in its sole discretion (but in no event later than May 13, 2026). Following the Special Meeting on May 13, 2025, the Board unanimously
approved, pursuant to NRS 78.2055, a reverse stock split of all issued and outstanding shares of the Company’s common stock, at
a ratio of 1-for-8 (the “ Reverse Stock Split”). The Reverse Stock Split will be implemented at 5:00 p. m. Eastern Time on June
6, 2025 (the “ Effective Time”) with trading commencing upon market opening on June 9, 2025.

The terms of the Reverse
Stock Split are such that every eight shares of the Company’s issued and outstanding common stock will automatically be combined
into one issued and outstanding share of common stock, without any change in par value per share. As a result of the Reverse Stock Split,
proportionate adjustments will be made to the per share exercise price and/or the number of shares issuable upon the exercise or vesting
of all then outstanding stock options, restricted stock units and warrants, which will result in a proportional decrease in the number
of shares of the Company’s common stock reserved for issuance upon exercise or vesting of such stock options, restricted stock units
and warrants, and, in the case of stock options and warrants, a proportional increase in the exercise price of all such stock options
and warrants. In addition, the number of shares reserved for issuance under the Company’s equity compensation plans immediately
prior to the Effective Time will be reduced proportionately.

No fractional shares
will be issued in connection with the Reverse Stock Split. Stockholders